Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Assets: 2020-2023

Historic Assets for Cullinan Therapeutics (CGEM) over the last 3 years, with Sep 2023 value amounting to $494.7 million.

  • Cullinan Therapeutics' Assets fell 19.85% to $494.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $494.7 million, marking a year-over-year decrease of 19.85%. This contributed to the annual value of $561.1 million for FY2022, which is 28.35% up from last year.
  • As of Q3 2023, Cullinan Therapeutics' Assets stood at $494.7 million, which was down 5.23% from $522.0 million recorded in Q2 2023.
  • In the past 5 years, Cullinan Therapeutics' Assets ranged from a high of $667.2 million in Q2 2022 and a low of $214.7 million during Q4 2020.
  • In the last 3 years, Cullinan Therapeutics' Assets had a median value of $494.7 million in 2023 and averaged $513.6 million.
  • Per our database at Business Quant, Cullinan Therapeutics' Assets skyrocketed by 103.62% in 2021 and then declined by 21.77% in 2023.
  • Over the past 4 years, Cullinan Therapeutics' Assets (Quarterly) stood at $214.7 million in 2020, then skyrocketed by 103.62% to $437.2 million in 2021, then rose by 28.35% to $561.1 million in 2022, then decreased by 19.85% to $494.7 million in 2023.
  • Its last three reported values are $494.7 million in Q3 2023, $522.0 million for Q2 2023, and $515.0 million during Q1 2023.